老虎證券

BUZZ-Silexion Therapeutics climbs on promising cancer drug data

Reuters
2025/09/30
BUZZ-Silexion <a href="https://laohu8.com/S/LENZ">Therapeutics</a> climbs on promising cancer drug data

** Shares of drug developer Silexion Therapeutics SLXN.O rise 11% to $3.75 premarket

** Says its experimental cancer drug, SIL204, showed strong activity in lab tests, targeting a wide range of KRAS mutations linked to aggressive cancers

** Reports inhibition rates between 83.5% and 99.7% in 11 human cancer cell lines, including its first data in gastric cancer and expanded results in colorectal cancer

** SIL204 also showed high potency against the G12R mutation, which affects about 17% of pancreatic cancer patients

** Plans to start mid-to-late stage trials in the first half of 2026

** As of last close, stock down 88% YTD

(Reporting by Kamal Choudhury in Bengaluru)

((Kamal.Choudhury@thomsonreuters.com;))

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10